|
|||||
|
|

Aerospace and defense company Cadre (NYSE:CDRE) announced better-than-expected revenue in Q2 CY2025, with sales up 8.9% year on year to $157.1 million. On the other hand, the company’s full-year revenue guidance of $627 million at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.32 per share was 7.9% above analysts’ consensus estimates.
Is now the time to buy CDRE? Find out in our full research report (it’s free).
Cadre’s second quarter saw a negative market reaction, with shares dropping sharply as investors digested both a revenue beat and a reduction in full-year guidance. Management cited resilient demand for its protection products and the addition of Carr’s Engineering to its nuclear safety business as key drivers for the quarter. However, the company acknowledged increased uncertainty in its operating environment, especially around the timing of large orders, which contributed to the cautious investor response. CEO Warren Kanders noted, “We continue to see strong and recurring demand for our suite of protection products...despite a fluid macro environment.”
Looking forward, Cadre’s guidance reflects shifting expectations around the timing of significant contracts, particularly in law enforcement and nuclear safety. Management emphasized that most delayed deals remain in the pipeline, but their realization may now extend into next year. CFO Blaine Browers said, “Guidance reflects our updated expectations around the timing of orders.” The company plans to offset margin pressures from tariffs and integration costs by leveraging operational efficiencies and further price increases. Management also highlighted ongoing M&A opportunities and anticipated that a stronger second half would be driven by project timing in the armor and explosive ordnance disposal (EOD) segments.
In Q2, Cadre’s performance was shaped by persistent demand across safety markets, the impact of recent M&A, and shifting order timing that influenced both results and guidance.
Management expects Cadre’s near-term outlook to be shaped by the timing of large project awards, ongoing integration of acquisitions, and the company’s ability to manage margin headwinds from tariffs and product mix.
Over the coming quarters, the StockStory team will be closely monitoring (1) the pace at which delayed large contracts in public safety and nuclear are awarded and recognized, (2) the success of cost management efforts to offset tariff and integration-related margin pressure, and (3) the realization of commercial and operational synergies from the Carr’s Engineering acquisition. Progress in these areas will be key to supporting a rebound in growth and profitability.
Cadre currently trades at $28.44, down from $34.62 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Nov-05 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-03 | |
| Nov-02 | |
| Oct-30 | |
| Oct-29 | |
| Oct-23 | |
| Oct-22 | |
| Oct-21 | |
| Oct-01 | |
| Sep-23 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite